Interestingly, in BC preclinical models this occurs independently of the effector caspase-3, as proven by the restoration of mitochondrial apoptosis in MCF-7 cells, probably unresponsive to some chemotherapeutics for an inherited lack of caspase-3 [57,158]. This evidence concerns the gene CASP3 and breast cancer.